PSYBIO THERAPEAUTICS (PSYBF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 60 212 sessions, November 7, 2023 to November 7, 2024
- Largest daily move
- +20900% close of October 15, 2024
- 1-year change
- -98.1% closing prices, November 7, 2023 to November 7, 2024
- 1-month change
- +0% closing prices, September 9, 2024 to November 7, 2024
Company Description
PSYBIO THERAPEAUTICS (OTC: PSYBF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $935.8K.
PSYBF has declined 98.1% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for PSYBF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PSYBIO THERAPEAUTICS (PSYBF) closed at $0.0001 on November 7, 2024. Over the past 12 months, the price has lost 98.1%.
PSYBF Metrics & Rankings
Price returns through November 7, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
PSYBIO THERAPEAUTICS has 3 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include conferences. View all PSYBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in PSYBIO THERAPEAUTICS (PSYBF) currently stands at 277.3 thousand shares, representing 0.3% of the float.
Days to Cover History
Days to cover for PSYBIO THERAPEAUTICS (PSYBF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 30.0 to 1000.0 days.
PSYBF Company Profile & Sector Positioning
PSYBIO THERAPEAUTICS (PSYBF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing PSYBF often look at related companies in the same sector, including YULONG ECO MATERIALS LTD (YECO), INNOVATION PHARMACEUTICAL (IPIX), SQZ BIOTECHNOLOGIES CO (SQZB), BRAXIA SCIENTIFIC CORP (BRAXF), and Biora Therapeutics, Inc. (BIOR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PSYBF's relative position within its industry.